Comments
Biopharmaceutical firm Suven Life Sciences reported a 153 per cent increase in net profit for the quarter ended September 30 at Rs 6.48 crore from Rs 2.5 crore in the year-ago period.
During the quarter, its revenues touched Rs 50.3 crore against Rs 48 crore in the corresponding quarter of last fiscal.
The company, which specialises in drug discovery central nervous system disorders, has invested Rs 15.6 crore in the last six months on R&D.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.